Product
Mycophenolate Sodium
2 clinical trials
20 indications
Indication
End-Stage Renal DiseaseIndication
Acute Lymphoblastic LeukemiaIndication
Acute Myeloid LeukemiaIndication
Diffuse Large B-Cell LymphomaIndication
Anaplastic Large Cell LymphomaIndication
Burkitt lymphomaIndication
Chronic Myeloid LeukemiaIndication
BCR-ABL1-positiveIndication
Chronic Myelomonocytic LeukemiaIndication
Hodgkin lymphomaIndication
Lymphoblastic LymphomaIndication
Waldenstrom MacroglobulinemiaIndication
mantle cell lymphomaIndication
Mixed Phenotype Acute LeukemiaIndication
Myelodysplastic SyndromeIndication
Prolymphocytic LeukemiaIndication
Refractory Chronic Lymphocytic LeukemiaIndication
Follicular LymphomaIndication
Marginal Zone LymphomaIndication
Small Lymphocytic LymphomaClinical trial
Head to Head Comparison of Myfortic vs. Cellcept in the Treatment of Kidney Transplant Recipients Using Our Current Center Standardized Concomitant Immunosuppressive ProtocolStatus: Completed
Clinical trial
Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Patients With Hematological Malignancies Using a Treosulfan-Based Preparative RegimenStatus: Recruiting, Estimated PCD: 2024-12-31